ABSTRACT The method for determining erythrocyte pyrimidine 5'-nucleotidase (P5N EC 3.1.3.5) activity has been simplified using an automated high performance liquid chromatograph (HPLC). The activity determined by the simplified method agreed closely with that obtained by conventional methods. In 161 lead workers P5N activity declined linearly with increasing blood lead concentrations (Pb-B) between 20 and 80 Mg/100g, and correlated well with Pb-B (r = -0 87). For the same group of workers, correlation coefficients between Pb-B v ALA-D activity, zinc protoporphyrin, ALA-U, and coproporphyrin were -0-87, 0-73, 0-70, and 0-32, respectively. At Pb-B > 40 pg/100 g, the validity of P5N (1 86 at a cut off of 10 < units) was higher than that of other indicators examined. P5N activity was fairly stable during the storage of samples for two weeks at 4°C. Determination of P5N activity by this method may be a useful indicator in screening for moderate exposure to lead.
Pyrimidine 5'-nucleotidase (P5N, EC 3.1.3.5) was first reported by Valentine et al in 1974 in their description of haemolytic anaemia.' The enzyme in the red cell cytosol catalyses the hydrolytic dephosphorylation of pyrimidine 5'-monophosphates but is ineffective on purine nucleotides. The reaction is thought to be a necessary step in the degradation of ribosomal RNA in maturing red cells. Through this mechanism, the erythrocyte is able to diffuse pyrimidine nucleotides as soluble nucleosides and retain purine nucleotides as a source of ATP.
The activity is extremely reduced in certain hereditary non-spherocytic anaemias and in lead poisoning.`-Many investigators have confirmed that the measurement of P5N activity has a diagnostic value for these disorders.46 Several workers have also reported negative linear correlations between blood lead concentrations and P5N activity in lead workers.3 [7] [8] [9] Thus the measurement of P5N activity appears to be a useful index of lead exposure or lead poisoning. Despite this, there have been few reports in which P5N activity has been determined as an index of lead exposure. The conventional method for measuring P5N activAccepted 24 March 1986 ity is based on the liberation of inorganic phosphorus from pyrimidine 5'-nucleotides and requires timeconsuming and complicated procedures, limiting its application in a clinical laboratory.'
We have previously developed a rapid and sensitive method of determining P5N activity, using reversed phase high performance liquid chromatography (HPLC) .'0 In the present paper we report on a further simplification of the method and its use in evaluating lead exposure. We have also studied the relation between P5N activity and other biological parameters of lead exposure.
Materials and methods
Heparinised venous blood was obtained from 161 lead workers who were employed in secondary smelters, glass factories, storage battery plants, and printing offices. To determine P5N activity, the erythrocytes were washed twice with a tenfold volume of saline (0 9% NaCI) and then suspended in the saline (about 50% suspension; RBC/saline). P5N activity was determined by the method previously reported'0 with some modifications. We modified the preparation of 840 Na (uridine 5'-monophosphate disodium salt) was used as the substrate without any purification instead of buffered substrate in the original method.8 The standard assay mixture contained 600 p1 of enzyme solution, 100 pl of 0-2M Tris-HCI buffer (pH 7 7) containing 75 mM MgCl2, and 50 p1 of 50 mM UMP-Na (Shigma Chemical Co, Saint Louis, USA). The reaction was started by adding the substrate at 37°C. After 60 minutes the reaction was terminated by placing the tubes in boiling water for three minutes. Then 2-25 ml of distilled water was added to the mixture and agitated. After centrifugation, the resulting supernatant was used for the HPLC analysis. A Shimadzu liquid chromatograph (Shimadzu, Kyoto, Japan) consisting of a pump (LC-3A), an automatic sample injector (SIL-2A), a column oven (CTO-2A), a variable wavelength spectrophotometer (SPD-1), and an integrator (C-RlA) was used. Flow rate, oven temperature, and detector wavelength were set at 1-0 ml/min, 40°C, and 254nm, respectively. The column (150 x 4mm) used was packed with reversed phase (ODS) silica. The mobile phase was 5% methanol containing 5 mM KH2PO4 and 0-2 mM 1-decanesulphonic acid. Samples were cooled at 4°C during a series of analyses, and 10 1u were automatically injected at seven minute intervals. The activity in dialysed erythrocytes was also determined by the original method,'0 using buffered substrate purified by ion exchanger. 
Results
In our original method commercially available UMP was purified by ion exchange chromatography to provide the low blank values for the assay. UMP (free acid) is a labile compound and spontaneously decomposes into uridine, which is found in small quantities as a contaminant in commercial UMP. UMP-Na is rather more stable than the free acid and in the present study UMP-Na was used as the substrate without any purification. Figure 1 shows the chromatographic separation of the product (uridine) from the substrate Sakai, Ushio and from erythrocyte constituents. Peak height or area of uridine shows P5N activity. Excellent resolution is achieved in less than four minutes. In the blank without addition of substrate there is no peak corresponding to uridine. Hence the blank for each sample may be omitted in routine analyses. In the blank without addition of enzyme solution a minute peak corresponding to uridine is detected, indicating that the substrate used contains a small amount of uridine as an impurity or a decomposition product. Thus the blank value must be subtracted from the uridine concentrations obtained. The data obtained by the present method (y) compared well with those using the original method (x): y = 1-003 x + 0-119, n = 28, r = 0-99 (data not shown).
In table I A simplified methodfor determining erythrocyte pyrimidine S'-nucleotidase (P5N) activity by HPLC 3) . ALA-D ("4C-CMP, cytidine 5'-monophosphate) was used as the substrate, which was adsorbed on to barium sulphate after the reaction had finished and the '4C-cytidine formed was counted with a liquid scintilation counter. This method eliminates the need for dialysis of the enzyme solution and is also extremely sensitive. The method cannot easily be carried out in every clinical laboratory, however.
In our assay P5N activity is also determined by measuring liberated pyrimidine nucleosides. The product is separated from the substrate and from red cell constituents by means of HPLC. In this method dialysis of the samples is not necessary and the incubation time is shortened because the amount of endogenous uridine is non-detectable and the intensity of the absorption of uridine at 254 nm is high. In our original method10 commercial UMP was purified by ion exchange chromatography to obtain UMP free from uridine. In the present method we used UMP-Na which is more stable than UMP (free acid) and eliminated the purification step. By these modifications the procedure was further simplified. Both methods gave identical results.
The mean control values (± SDs) for P5N activity have been reported as 7.1,1 6-6 + 2.0,2 7-38 + 2-56,4 9.9 + 25,3 7-51 + 0-86,5 and 12-9 + 2.9. Mg/lOOg (fig 3) and ALA-U and CP-U also increase exponentially with Pb-B over 40 Mg/IOOg (fig 3) .
These results are comparable with those reported previously. 1 8 Strong correlations were found between P5N activity and other biological indicators of lead effect (table  3) . Correlation coefficients between log P5N and log ALA-D, log ZP, log ALA-U, and log CP-U were 844 0 73, -0-68, -0-62, and -0-36, respectively. These data compare with the correlations reported by Mohammed-Brahim et al,9 whose correlation coefficients of log P5N v log ALA-D, log ZP, and log ALA-U were 0-76, -0-79, and -0-60, respectively. The strong correlations between P5N and other biological parameters suggest that the decrease in P5N activity is able to predict the disturbance which lead induces in haem biosynthesis. In male workers exposed to lead and other heavy metals MohammedBrahim et al reported the validity of P5N and ZP as 1-71 and 1-73, respectively, when Pb-B values were greater than 40 ug/100 ml.9 In the present study we obtained a high validity for P5N (1-86 at a cut off of < 10 units) at Pb-B > 40 pg/lOOg and this was higher than those of the other indicators examined (table 4) . This indicates that P5N is a good discriminator at moderate Pb-B values.
Although ALA-D activity is the most sensitive indicator of lead exposure and widely used for this purpose, one disadvantage of the test is that the assay must be carried out immediately after sampling. The enzyme is vulnerable and inactivated during storage. To solve this problem we routinely determine the activity ratio by heat treatment or zinc activation or both, of ALA-D in stored samples." 19 P5N, by contrast, is relatively stable at 4°C (table 5) . Torrance et al reported that the reduction of P5N activity was only 1-4% after storage of samples for seven days at 4°C. 5 As the assay of P5N can be carried out with stored samples, it seems to be more suitable than ALA-D for screening lead exposure.
